FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma. (Q55068271)
Jump to navigation
Jump to search
scientific article published on 2 February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma. |
scientific article published on 2 February 2015 |
Statements
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma. (English)
1 reference
Barry W Miller
1 reference
Donna Przepiorka
1 reference
R Angelo de Claro
1 reference
Kyung Lee
1 reference
Lei Nie
1 reference
Natalie Simpson
1 reference
Ramadevi Gudi
1 reference
Haleh Saber
1 reference
Stacy Shord
1 reference
Julie Bullock
1 reference
Dhananjay Marathe
1 reference
Nitin Mehrotra
1 reference
Li Shan Hsieh
1 reference
Debasis Ghosh
1 reference
Janice Brown
1 reference
Robert C Kane
1 reference
Robert Justice
1 reference
Edvardas Kaminskas
1 reference
Ann T Farrell
1 reference
Richard Pazdur
1 reference
2 February 2015
1 reference
21
1 reference
7
1 reference
1525-1529
1 reference